Local VEGF‐A blockade modulates the microenvironment of the corneal graft bed

The microenvironment plays an important role in several immunological processes. Vascular endothelial growth factor‐A (VEGF‐A) not only regulates angiogenesis, but is known as a modulator of the immune microenvironment. Modulating the site of transplantation might be beneficial for subsequent transplant survival. In this study, we therefore analyzed the effect that a local blockade of VEGF‐A in the inflamed cornea as the graft receiving tissue has on the immune system. We used the murine model of suture‐induced neovascularization and subsequent high‐risk corneal transplantation, which is an optimal model for local drug application. Mice were treated with VEGFR1/R2 trap prior to transplantation. We analyzed corneal gene expression, as well as protein levels in the cornea and serum on the day of transplantation, 2 and 8 weeks later. Local VEGF depletion prior to transplantation increases the expression of pro‐inflammatory as well as immune regulatory cytokines only in the corneal microenvironment, but not in the serum. Furthermore, local VEGFR1/R2 trap treatment significantly inhibits the infiltration of CD11c+ dendritic cells into the cornea. Subsequent increased corneal transplantation success was accompanied by a local upregulation of Foxp3 gene expression. This study demonstrates that locally restricted VEGF depletion increases transplantation success by modulating the receiving corneal microenvironment and inducing tolerogenic mechanisms.

[1]  J. Horstmann,et al.  UV light crosslinking regresses mature corneal blood and lymphatic vessels and promotes subsequent high‐risk corneal transplant survival , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[2]  C. Cursiefen,et al.  Fine Needle-Diathermy Regresses Pathological Corneal (Lymph)Angiogenesis and Promotes High-Risk Corneal Transplant Survival , 2018, Scientific Reports.

[3]  A. Gilman‐Sachs,et al.  Early pregnancy immune biomarkers in peripheral blood may predict preeclampsia. , 2018, Journal of reproductive immunology.

[4]  R. Dana,et al.  Treatment of donor corneal tissue with immunomodulatory cytokines: a novel strategy to promote graft survival in high-risk corneal transplantation , 2017, Scientific Reports.

[5]  Trushar R. Patel,et al.  Structural decoding of netrin-4 reveals a regulatory function towards mature basement membranes , 2016, Nature Communications.

[6]  R. Dana,et al.  Graft Site Microenvironment Determines Dendritic Cell Trafficking Through the CCR7-CCL19/21 Axis , 2016, Investigative ophthalmology & visual science.

[7]  S. Jalkanen,et al.  G-CSF regulates macrophage phenotype and associates with poor overall survival in human triple-negative breast cancer , 2015, Oncoimmunology.

[8]  S. Govoni,et al.  Targeting VEGF in eye neovascularization: What's new?: A comprehensive review on current therapies and oligonucleotide-based interventions under development. , 2016, Pharmacological research.

[9]  R. Dana,et al.  VEGF-trap Aflibercept Significantly Improves Long-term Graft Survival in High-risk Corneal Transplantation , 2015, Transplantation.

[10]  G. Han,et al.  Effects of Foxp3 gene modified dendritic cells on mouse corneal allograft rejection. , 2015, International journal of clinical and experimental medicine.

[11]  C. Cursiefen,et al.  Antilymphangiogenic therapy to promote transplant survival and to reduce cancer metastasis: what can we learn from the eye? , 2015, Seminars in cell & developmental biology.

[12]  R. Dana,et al.  Corneal Lymphatics: Role in Ocular Inflammation as Inducer and Responder of Adaptive Immunity , 2014, Journal of clinical & cellular immunology.

[13]  D. Meller,et al.  Aganirsen antisense oligonucleotide eye drops inhibit keratitis-induced corneal neovascularization and reduce need for transplantation: the I-CAN study. , 2014, Ophthalmology.

[14]  U. Schraermeyer,et al.  Effects of a Single Intravitreal Injection of Aflibercept and Ranibizumab on Glomeruli of Monkeys , 2014, PloS one.

[15]  C. Cursiefen,et al.  Blockade of the VEGF isoforms in inflammatory corneal hemangiogenesis and lymphangiogenesis , 2014, Graefe's Archive for Clinical and Experimental Ophthalmology.

[16]  E. Tartour,et al.  Control of the Immune Response by Pro-Angiogenic Factors , 2014, Front. Oncol..

[17]  C. Cursiefen,et al.  Topical Ranibizumab inhibits inflammatory corneal hem‐ and lymphangiogenesis , 2014, Acta ophthalmologica.

[18]  P. Hamrah,et al.  Corneal Allograft Rejection: Immunopathogenesis to Therapeutics , 2013, Journal of clinical & cellular immunology.

[19]  R. González-Amaro,et al.  CCL22-Producing CD8α− Myeloid Dendritic Cells Mediate Regulatory T Cell Recruitment in Response to G-CSF Treatment , 2013, The Journal of Immunology.

[20]  L. Boon,et al.  Topical Application of Soluble CD83 Induces IDO-Mediated Immune Modulation, Increases Foxp3+ T Cells, and Prolongs Allogeneic Corneal Graft Survival , 2013, The Journal of Immunology.

[21]  P. Berggren,et al.  Role of T Cell Recruitment and Chemokine‐Regulated Intra‐Graft T Cell Motility Patterns in Corneal Allograft Rejection , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[22]  A. Teixeira-Carvalho,et al.  Severe preeclampsia goes along with a cytokine network disturbance towards a systemic inflammatory state. , 2013, Cytokine.

[23]  M. Sade-Feldman,et al.  Tumor necrosis factor-α blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation. , 2013, Immunity.

[24]  J. Niederkorn Corneal Transplantation and Immune Privilege , 2013, International reviews of immunology.

[25]  F. Kruse,et al.  Angioregressive Pretreatment of Mature Corneal Blood Vessels Before Keratoplasty: Fine-Needle Vessel Coagulation Combined With Anti-VEGFs , 2012, Cornea.

[26]  M. Sade-Feldman,et al.  New insights into chronic inflammation-induced immunosuppression. , 2012, Seminars in cancer biology.

[27]  N. Mukaida,et al.  Critical role of TNF-α-induced macrophage VEGF and iNOS production in the experimental corneal neovascularization. , 2012, Investigative ophthalmology & visual science.

[28]  G. Yancopoulos,et al.  Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab , 2012, Angiogenesis.

[29]  D. Schadendorf,et al.  Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model , 2011, Proceedings of the National Academy of Sciences.

[30]  Peter W. Chen,et al.  IL-17A–Dependent CD4+CD25+ Regulatory T Cells Promote Immune Privilege of Corneal Allografts , 2011, The Journal of Immunology.

[31]  J. Niederkorn,et al.  High-risk corneal allografts and why they lose their immune privilege , 2010, Current opinion in allergy and clinical immunology.

[32]  Claus Cursiefen,et al.  Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis. , 2010, Ophthalmology.

[33]  D. Azar,et al.  VEGF TrapR1R2 Suppresses Experimental Corneal Angiogenesis , 2010, European journal of ophthalmology.

[34]  S. Wiegand,et al.  Cutting Edge: Lymphatic Vessels, Not Blood Vessels, Primarily Mediate Immune Rejections After Transplantation , 2009, The Journal of Immunology.

[35]  J. Pollard,et al.  Microenvironmental regulation of metastasis , 2009, Nature Reviews Cancer.

[36]  R. Dana,et al.  Transient postoperative vascular endothelial growth factor (VEGF)-neutralisation improves graft survival in corneas with partly regressed inflammatory neovascularisation , 2009, British Journal of Ophthalmology.

[37]  R. Dana,et al.  Levels of Foxp3 in Regulatory T Cells Reflect Their Functional Status in Transplantation1 , 2009, The Journal of Immunology.

[38]  F. Horn,et al.  Improved semiautomatic method for morphometry of angiogenesis and lymphangiogenesis in corneal flatmounts. , 2008, Experimental eye research.

[39]  Y. Belkaid,et al.  Review Tuning Microenvironments: Induction of Regulatory T Cells by Dendritic Cells Induction of Foxp3 + Treg Cells by Dcs , 2022 .

[40]  K. Maruyama,et al.  Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation. , 2008, Archives of ophthalmology.

[41]  H. Volk,et al.  Effects of interleukin-12p40 gene transfer on rat corneal allograft survival. , 2007, Transplant immunology.

[42]  Björn Bachmann,et al.  Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis. , 2007, Investigative ophthalmology & visual science.

[43]  D. Dix,et al.  Inhibition of Corneal Angiogenesis by Topical Administration of VEGF Trap , 2007 .

[44]  J. Niederkorn Immune Mechanisms of Corneal Allograft Rejection , 2007, Current eye research.

[45]  Flora Zavala,et al.  Granulocyte Colony-Stimulating Factor: A Novel Mediator of T Cell Tolerance1 , 2005, The Journal of Immunology.

[46]  M. Dana,et al.  Early ocular chemokine gene expression and leukocyte infiltration after high-risk corneal transplantation. , 2005, Molecular vision.

[47]  J. Scheerlinck,et al.  Prolongation of Sheep Corneal Allograft Survival by Transfer of the Gene Encoding Ovine IL-12-p40 but Not IL-4 to Donor Corneal Endothelium1 , 2005, The Journal of Immunology.

[48]  M. Dana,et al.  CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium. , 2005, Investigative ophthalmology & visual science.

[49]  K. Maruyama,et al.  Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. , 2004, Investigative ophthalmology & visual science.

[50]  Jingtai Cao,et al.  VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. , 2004, The Journal of clinical investigation.

[51]  M. Kuwano,et al.  Induction of macrophage inflammatory protein-1α and vascular endothelial growth factor during inflammatory neovascularization in the mouse cornea , 2004, Angiogenesis.

[52]  S. Yoshida,et al.  Involvement of Macrophage Chemotactic Protein-1 and Interleukin-1β During Inflammatory but Not Basic Fibroblast Growth Factor–Dependent Neovascularization in the Mouse Cornea , 2003, Laboratory Investigation.

[53]  F. Kruse,et al.  High expression of chemokines Gro-alpha (CXCL-1), IL-8 (CXCL-8), and MCP-1 (CCL-2) in inflamed human corneas in vivo. , 2003, Archives of ophthalmology.

[54]  Claus Cursiefen,et al.  Corneal Lymphangiogenesis: Evidence, Mechanisms, and Implications for Corneal Transplant Immunology , 2003, Cornea.

[55]  H. Iwasaki,et al.  Monocyte Chemoattractant Protein-1 Selectively Inhibits the Acquisition of CD40 Ligand-Dependent IL-12-Producing Capacity of Monocyte-Derived Dendritic Cells and Modulates Th1 Immune Response1 , 2002, The Journal of Immunology.

[56]  F. Thaiss,et al.  Expression of the chemokines MCP-1/CCL2 and RANTES/CCL5 is differentially regulated by infiltrating inflammatory cells. , 2002, Kidney international.

[57]  小川 聡一郎 Induction of macrophage inflammatory protein-1α and vascular endothelial growth factor during inflammatory neovascularization in the mouse cornea , 2002 .

[58]  H. Ochi,et al.  Concentrations of serum granulocyte-colony-stimulating factor in normal pregnancy and preeclampsia. , 1999, Hypertension in pregnancy.

[59]  D. Carbone,et al.  Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells. , 1998, Journal of immunology.

[60]  M. T. Tran,et al.  Proinflammatory cytokines induce RANTES and MCP-1 synthesis in human corneal keratocytes but not in corneal epithelial cells. Beta-chemokine synthesis in corneal cells. , 1996, Investigative ophthalmology & visual science.

[61]  S. Soker,et al.  Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. , 1995, Cancer research.

[62]  J. Streilein,et al.  ORTHOTOPIC CORNEAL TRANSPLANTATION IN MICE—EVIDENCE THAT THE IMMUNOGENETIC RULES OF REJECTION DO NOT APPLY , 1992, Transplantation.